One-Time Intrathecal Administration of AAV5-miATXN3 in Non-Human Primates

被引：0
|
作者：
Evers, Melvin M. [1 ]
Toonen, Lodewijk [1 ]
Spronck, Lisa [1 ]
Brouwers, Cynthia [1 ]
Mariet, Fanny [1 ]
Baatje, Sumiati [1 ]
Schwarz, Lukas [1 ]
van Deventer, Sander [1 ]
Sier-Ferreira, Valerie [1 ]
de Haan, Martin [1 ]
Valles, Astrid [1 ]
Konstantinova, Pavlina [1 ]
机构：
[1] UniQure, Amsterdam, Netherlands
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
491
引用
收藏
页码：215 / 216
页数：2
相关论文
共 50 条
  • [21] Intraparenchymal Administration to the Striatum of a Barcoded AAV Library for the Characterization of Capsid Tropisms in Rodents and Non-Human Primates
    Lee, Jun Young
    Yoon, A-Rum
    Thambi, Thavasyappan
    Jo, Sung-Ha
    Choi, Yong-Hyeon
    Langer, Robert
    Devinsky, Orrin
    Yun, Chae-Ok
    MOLECULAR THERAPY, 2022, 30 (04) : 422 - 423
  • [22] PET imaging of macromolecule and particle delivery to the brain through intrathecal administration in rodents and non-human primates
    Papisov, Mikhail
    Belov, Vasily
    Fischman, Alan
    Titus, James
    Gillooly, Caitlin
    Gagne, Matthew
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [23] Comparable efficiency of photoreceptor transduction by AAV2tYF, AAV5 and AAV8 in non-human primates
    Shearman, M. S.
    Song, C. J.
    Ye, G.
    Timmers, A. M.
    Newmark, J.
    HUMAN GENE THERAPY, 2018, 29 (12) : A153 - A153
  • [24] Successful Repeated Hepatic Gene Delivery in Mice and Non-Human Primates Achieved by Sequential Administration of AAV5 and AAV1 Vector Serotypes
    Majowicz, Anna
    Salas, David
    Zabaleta, Nerea
    Rodriguez-Garcia, Estefania
    Gonzalez Aseguinolaza, Gloria
    Petry, Harald
    Ferreira, Valerie
    MOLECULAR THERAPY, 2016, 24 : S277 - S277
  • [25] AAV9 biodistribution and expression in the PNS of Non-Human Primates
    Kagiava, A.
    Casy, W.
    Trygg, C.
    Braun, S. E.
    Gray, S. J.
    Kleopa, K. A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A37 - A37
  • [26] Biodistribution and Safety Study of AAV9 in Non-Human Primates
    Lostal, William
    Roudaut, Carinne
    Deschamps, Jack-Yves
    Richard, Isabelle
    MOLECULAR THERAPY, 2018, 26 (05) : 190 - 190
  • [27] Prevalence of AAV 1, 2, 3, 5, 6, 8, 9 and 10 neutralizing factors in non-human primates
    Couzinie, C.
    Le Duff, J.
    Jaulin, N.
    Devaux, M.
    Borderon, N.
    Adjali, O.
    HUMAN GENE THERAPY, 2018, 29 (12) : A147 - A148
  • [28] Para-Retinal Administration of AAV204, a Novel AAV Capsid for the Treatment of Inherited Retinal Dystrophies, in Non-Human Primates
    Kevany, Brian
    Kerns, Scott
    Padegimas, Linas
    MOLECULAR THERAPY, 2022, 30 (04) : 436 - 437
  • [29] Optimization of intrathecal delivery of an infused AAV9 vector for delivery of a gene therapy candidate for adrenomyeloneuropathy in non-human primates
    Vasireddy, V.
    Clark, S. W.
    Anderson, D. W.
    Kozarsky, K.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A27 - A27
  • [30] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
12345